Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B
Volume
44
Pagination
957 - 966
DOI
10.1111/apt.13779
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Issue
ISSN
0269-2813
Metadata
Show full item recordAuthors
Marcellin, P; Ahn, SH; Chuang, W-L; Hui, AJ; Tabak, F; Mehta, R; Petersen, J; Lee, C-M; Ma, X; Caruntu, FACollections
- Centre for Immunobiology [607]
